Inflammation and Exosomes in Fabry Disease Pathogenesis
Cells · 2024
DOI: 10.3390/cells13080654 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Bruna Coelho-Ribeiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Fabry Disease, Inflammation, Exosomes. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amicus Therapeutics (United Kingdom), Component C5 - Capitalisation and Business Innovation, under the Portuguese Resilience and Recovery Plan, through the NextGenerationEU Fund., Foundation for Science and Technology (FCT).
Abstract (Originalsprache)
Fabry Disease (FD) is one of the most prevalent lysosomal storage disorders, resulting from mutations in the GLA gene located on the X chromosome. This genetic mutation triggers glo-botriaosylceramide (Gb-3) buildup within lysosomes, ultimately impairing cellular functions. Given the role of lysosomes in immune cell physiology, FD has been suggested to have a profound impact on immunological responses. During the past years, research has been focusing on this topic, and pooled evidence strengthens the hypothesis that Gb-3 accumulation potentiates the production of pro-inflammatory mediators, revealing the existence of an acute inflammatory process in FD that possibly develops to a chronic state due to stimulus persistency. In parallel, extracellular vesicles (EVs) have gained attention due to their function as intercellular communicators. Considering EVs’ capacity to convey cargo from parent to distant cells, they emerge as potential inflammatory intermediaries capable of transporting cytokines and other immunomodulatory molecules. In this review, we revisit the evidence underlying the association between FD and altered immune responses and explore the potential of EVs to function as inflammatory vehicles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), 4710-057 Braga, Portugal.
- ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga/4805-017 Guimarães, Portugal.
- Reference Center on Lysosomal Storage Disorders, Hospital Senhora da Oliveira, 4835-044 Guimarães, Portugal.
ORCID-Profile: Helena G Silva, Belém Sampaio-Marques, Alexandra G Fraga, Paula Ludovico
Förderung
- Amicus Therapeutics (United Kingdom)
- Component C5 - Capitalisation and Business Innovation, under the Portuguese Resilience and Recovery Plan, through the NextGenerationEU Fund.
- Foundation for Science and Technology (FCT)
- national funds
- Component C5—Capitalisation and Business Innovation
- Foundation for Science and Technology (FCT)—project
Zitieren
APA
Coelho-Ribeiro, B., Silva, H. G., Sampaio-Marques, B., Fraga, A. G., Azevedo, O., Pedrosa, J., & Ludovico, P. (2024). Inflammation and Exosomes in Fabry Disease Pathogenesis. Cells. https://doi.org/10.3390/cells13080654
Vancouver
Coelho-Ribeiro B, Silva HG, Sampaio-Marques B, Fraga AG, Azevedo O, Pedrosa J, et al. Inflammation and Exosomes in Fabry Disease Pathogenesis. Cells. 2024. doi:10.3390/cells13080654
BibTeX
@article{CoelhoRibeiro2024,
author = {Coelho-Ribeiro, Bruna and Silva, Helena G and Sampaio-Marques, Belém and Fraga, Alexandra G and Azevedo, Olga and Pedrosa, Jorge and Ludovico, Paula},
title = {Inflammation and Exosomes in Fabry Disease Pathogenesis},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13080654}
}
EUVIMED